2014

  1. Winiarska M, Bojarczuk K, Pyrzynska B, Bil J, Siernicka M, Dwojak M, BobrowiczM, Miazek N, Zapala P, Zagozdzon A, Krol M, Syta A, Podszywalow-Bartnicka P,Pilch Z, Dabrowska-Iwanicka A, Juszczynski P, Efremov DG, Slabicki M, Zenz T, Le Roy A, Olive D, Rygiel TP, Leusen JH, Golab J. Inhibitors of SRC kinases impairantitumor activity of anti-CD20 monoclonal antibodies. MAbs. 2014;6(5):1300-13.doi: 10.4161/mabs.32106. Epub 2014 Oct 30.
  2. Nowis D, Malenda A, Furs K, Oleszczak B, Sadowski R, Chlebowska J, Firczuk M, Bujnicki JM, Staruch AD, Zagozdzon R, Glodkowska-Mrowka E, Szablewski L, Golab J.Statins impair glucose uptake in human cells. BMJ Open Diabetes Res Care. 2014Apr 26;2(1):e000017. doi: 10.1136/bmjdrc-2014-000017
  3. Mlynarczuk-Bialy I, Doeppner TR, Golab J, Nowis D, Wilczynski GM, Parobczak K,Wigand ME, Hajdamowicz M, Biały LP, Aniolek O, Henklein P, Bähr M, Schmidt B,Kuckelkorn U, Kloetzel PM. Biodistribution and Efficacy Studies of the ProteasomeInhibitor BSc2118 in a Mouse Melanoma Model. Transl Oncol. 2014 Oct24;7(5):570-9. doi: 10.1016/j.tranon.2014.07.002.
  4. Serda M, Kalinowski DS, Rasko N, Potůčková E, Mrozek-Wilczkiewicz A, Musiol R,Małecki JG, Sajewicz M, Ratuszna A, Muchowicz A, Gołąb J, Simůnek T, RichardsonDR, Polanski J. Exploring the anti-cancer activity of novel thiosemicarbazonesgenerated through the combination of retro-fragments: dissection of criticalstructure-activity relationships. PLoS One. 2014 Oct 16;9(10):e110291. doi:10.1371/journal.pone.0110291.
  5. Wachowska M, Gabrysiak M, Golab J. Epigenetic remodeling combined withphotodynamic therapy elicits anticancer immune responses. Oncoimmunology. 2014May 15;3:e28837.
  6. O'Leary PC, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A,O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX,Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM.Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-inducedsuppression and is a protein biomarker of favorable prognosis in breast cancer.Breast Cancer Res. 2014 Jul 10;16(4):R79. doi: 10.1186/bcr3691.  
  7. Mrozek-Wilczkiewicz A, Serda M, Musiol R, Malecki G, Szurko A, Muchowicz A,Golab J, Ratuszna A, Polanski J. Iron chelators in photodynamic therapyrevisited: synergistic effect by novel highly active thiosemicarbazones. ACS Med Chem Lett. 2014 Jan 23;5(4):336-9. doi: 10.1021/ml400422a.  2014 Apr10.   24900837;
  8. van den Borne P, Rygiel TP, Hoogendoorn A, Westerlaken GH, Boon L, Quax PH,Pasterkamp G, Hoefer IE, Meyaard L. The CD200-CD200 receptor inhibitory axiscontrols arteriogenesis and local T lymphocyte influx. PLoS One. 2014 Jun4;9(6):e98820. doi: 10.1371/journal.pone.0098820.
  9. Glodkowska-Mrowka E, Mrowka P, Basak GW, Niesiobedzka-Krezel J, Seferynska I, Wlodarski PK, Jakobisiak M, Stoklosa T. Statins inhibit ABCB1 and ABCG2 drugtransporter activity in chronic myeloid leukemia cells and potentiateantileukemic effects of imatinib. Exp Hematol. 2014 Jun;42(6):439-47. doi:
  10. Muchowicz A, Firczuk M, Chlebowska J, Nowis D, Stachura J, Barankiewicz J,Trzeciecka A, Kłossowski S, Ostaszewski R, Zagożdżon R, Pu JX, Sun HD, Golab J.Adenanthin targets proteins involved in the regulation of disulphide bonds.Biochem Pharmacol. 2014 May 15;89(2):210-6. doi: 10.1016/j.bcp.2014.02.022.
  11. Wachowska M, Gabrysiak M, Muchowicz A, Bednarek W, Barankiewicz J, Rygiel T, Boon L, Mroz P, Hamblin MR, Golab J. 5-Aza-2'-deoxycytidine potentiatesantitumour immune response induced by photodynamic therapy. Eur J Cancer. 2014May;50(7):1370-81. doi: 10.1016/j.ejca.2014.01.017. Epub 2014 Feb 18.
  12. Lasek W, Zagożdżon R, Jakobisiak M. Interleukin 12: still a promisingcandidate for tumor immunotherapy? Cancer Immunol Immunother. 2014May;63(5):419-35. doi: 10.1007/s00262-014-1523-1. Epub 2014 Feb 11. Review.
  13. Machnicki MM, Stoklosa T. BRAF--a new player in hematological neoplasms.Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):77-83. doi: 10.1016/j.bcmd.2014.01.001.Epub 2014 Feb 2.
  14. Glodkowska-Mrowka E, Solarska I, Mrowka P, Bajorek K, Niesiobedzka-Krezel J, Seferynska I, Borg K, Stoklosa T. Differential expression of BIRC family genes inchronic myeloid leukaemia--BIRC3 and BIRC8 as potential new candidates toidentify disease progression. Br J Haematol. 2014 Mar;164(5):740-2. doi:10.1111/bjh.12663.
  15. Kilarski WW, Muchowicz A, Wachowska M, Mężyk-Kopeć R, Golab J, Swartz MA,Nowak-Sliwinska P. Optimization and regeneration kinetics of lymphatic-specificphotodynamic therapy in the mouse dermis. Angiogenesis. 2014 Apr;17(2):347-57.doi: 10.1007/s10456-013-9365-6. Epub 2013 Jul 28.